We are live on ! Find out more
GCIA

Gabelli & Co Investment Advisers Portfolio holdings

AUM $674M
1-Year Est. Return 64.46%
This Fund
S&P 500
This Quarter Est. Return
+14.52%
1 Year Est. Return
+64.46%
3 Year Est. Return
+233.2%
5 Year Est. Return
+564.06%
10 Year Est. Return
+5,311.56%
AUM
$651M
AUM Growth
-$10.4M
Cap. Flow
-$40.4M
Cap. Flow %
-6.21%
Top 10 Hldgs %
33.34%
Holding
313
New
62
Increased
51
Reduced
31
Closed
48

Top Buys

Rank Stock Value
1
BPMC
Blueprint Medicines
BPMC
+$19M
2
SKX
Skechers
SKX
+$16.5M
3
SWTX
SpringWorks Therapeutics
SWTX
+$12.6M
4
WBA
Walgreens Boots Alliance
WBA
+$9.26M
5
DNB
Dun & Bradstreet
DNB
+$7.98M

Top Sells

Rank Stock Value
1
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$26.7M
2
FNA
Paragon 28, Inc.
FNA
+$18.3M
3
BECN
Beacon Roofing Supply, Inc.
BECN
+$18M
4
DFS
Discover Financial Services
DFS
+$16.7M
5
DESP
Despegar.com
DESP
+$12.8M

Sector Composition

Rank Sector Weight
1 Healthcare 17.22%
2 Communication Services 15.3%
3 Technology 11.49%
4 Industrials 8.49%
5 Consumer Discretionary 8.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SMG icon
176
ScottsMiracle-Gro
SMG
$3.61B
$310K 0.05%
+4,700
New +$272K
AAPL icon
177
Apple
AAPL
$4.45T
$308K 0.05%
1,500
– –
HPE icon
178
Hewlett Packard
HPE
$72B
$307K 0.05%
15,000
– –
BAX icon
179
Baxter International
BAX
$14.3B
$303K 0.05%
+10,000
New +$303K
AAP icon
180
Advance Auto Parts
AAP
$3.19B
$302K 0.05%
6,500
– –
CZR icon
181
Caesars Entertainment
CZR
$6.06B
$298K 0.05%
10,500
+1,000
+11% +$27.2K
CI icon
182
Cigna
CI
$72.4B
$298K 0.05%
900
– –
WFC.PRL icon
183
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
$4.66B
$294K 0.05%
250
– –
GENVR
184
Gen Digital Inc Contingent Value Rights
GENVR
$290K 0.04%
+36,200
New +$254K
TSLA icon
185
Tesla
TSLA
$1.31T
$286K 0.04%
900
– –
ALCY
186
DELISTED
Alchemy Investments Acquisition Corp 1
ALCY
$282K 0.04%
24,100
– –
THC icon
187
Tenet Healthcare
THC
$20.9B
$282K 0.04%
1,600
-1,000
-38% -$151K
APP icon
188
Applovin
APP
$107B
$280K 0.04%
800
– –
ABBV icon
189
AbbVie
ABBV
$442B
$278K 0.04%
1,500
– –
SPKL
190
Spark I Acquisition Corp
SPKL
$101M
$276K 0.04%
25,300
– –
TME icon
191
Tencent Music
TME
$14.3B
$273K 0.04%
14,000
-8,000
-36% -$126K
CHE icon
192
Chemed
CHE
$7.02B
$268K 0.04%
+550
New +$313K
BDX icon
193
Becton Dickinson
BDX
$49.4B
$267K 0.04%
1,550
+500
+48% +$91.6K
UNH icon
194
UnitedHealth
UNH
$361B
$257K 0.04%
825
+175
+27% +$66.9K
INTC icon
195
Intel
INTC
$493B
$254K 0.04%
11,350
+2,000
+21% +$41.4K
TEVA icon
196
Teva Pharmaceuticals
TEVA
$42.5B
$251K 0.04%
15,000
– –
BKHA
197
Black Hawk Acquisition Corp
BKHA
$48.9M
$249K 0.04%
23,400
– –
WMT icon
198
Walmart Inc
WMT
$901B
$244K 0.04%
2,500
– –
TTWO icon
199
Take-Two Interactive
TTWO
$46.8B
$243K 0.04%
1,000
– –
CLX icon
200
Clorox
CLX
$13.1B
$240K 0.04%
2,000
– –
6 7
8
9 10

Similar funds

RCM
Redwood Capital Management New York $674M AUM 99.78% 1-Year Est. Return
DPC
Dream Peak Capital Hong Kong $675M AUM
BFA
Blueprint Financial Advisors Greensboto, North Carolina $675M AUM 24.91% 1-Year Est. Return
CCM
Corsair Capital Management New York $673M AUM 109.99% 1-Year Est. Return
CHCM
Columbus Hill Capital Management Short Hills, New Jersey $673M AUM 24.63% 1-Year Est. Return
JC
JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return
NI
Noked Israel Ramat Hasharon, Israel $677M AUM 69.37% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return

Gabelli & Co Investment Advisers's Q2 2025 Portfolio in Review

As of Q2 2025, Gabelli & Co Investment Advisers held 313 positions worth $651M, down 1.6% from $662M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Gabelli & Co Investment Advisers withdrew a net $40.4M in Q2 2025, closing 48 positions and reducing 31 holdings. Its most notable exit was Intra-Cellular Therapies Inc., an estimated $26.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Communication Services and Technology.

Against the trend, Gabelli & Co Investment Advisers opened a new position in Blueprint Medicines worth $23.5M.

  • Gabelli & Co Investment Advisers's largest Q2 2025 buy was Blueprint Medicines: 183,374 shares worth $23.5M.
  • Gabelli & Co Investment Advisers added most to SpringWorks Therapeutics in Q2 2025, an estimated $12.6M increase.
  • Gabelli & Co Investment Advisers's biggest Q2 2025 reduction was Albertsons Companies, cutting an estimated $4.03M.
  • Gabelli & Co Investment Advisers fully exited Intra-Cellular Therapies Inc. in Q2 2025, selling an estimated $26.7M.
  • Gabelli & Co Investment Advisers's ten largest holdings make up 33% of its $651M portfolio in Q2 2025.
  • Gabelli & Co Investment Advisers opened 62 new positions and closed 48 in Q2 2025.
  • Gabelli & Co Investment Advisers's portfolio value fell 1.6% quarter-over-quarter to $651M.

Based on Gabelli & Co Investment Advisers's 13F filing for Q2 2025, filed 13 Aug 2025.